Sigal Kaplan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Emergency Department

Cardiovascular Events

Top Venues

Pharmacoepidemiology and drug safety

Current medical research and opinion

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rosa Gini, Romin Pajouheshnia, Helga Gardarsdottir, Dimitri Bennett, Lin Li, Claudia Gulea, Angelika Wientzek-Fleischmann, Marloes T Bazelier, Mehmet Burcu, Caitlin N Dodd, Carlos E Durán, Sigal Kaplan, Stephan Lanes, Karine Marinier, Giuseppe Roberto, Kanaka Soman, Xiaofeng Zhou, Robert W Platt, Soko Setoguchi, Gillian C Hall
Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and drug safety 33 (5) (2024)
Sigal Kaplan, Claudia Florentina Dragut, Andra Ghimpeteanu
Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate. Current medical research and opinion (2024)
Sigal Kaplan, Claudia Florentina Dragut, Andra Ghimpeteanu
Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate. Current medical research and opinion 40 (5) (2024)
Sigal Kaplan, Claudia Florentina Dragut, Andra Ghimpeteanu
Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate. Current medical research and opinion (2024)
Sigal Kaplan, Claudia Florentina Dragut, Andra Ghimpeteanu
Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate. Current medical research and opinion 40 (5) (2024)
Rosa Gini, Romin Pajouheshnia, Helga Gardarsdottir, Dimitri Bennett, Lin Li, Claudia Gulea, Angelika Wientzek-Fleischmann, Marloes T Bazelier, Mehmet Burcu, Caitlin N Dodd, Carlos E Durán, Sigal Kaplan, Stephan Lanes, Karine Marinier, Giuseppe Roberto, Kanaka Soman, Xiaofeng Zhou, Robert W Platt, Soko Setoguchi, Gillian C Hall
Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and drug safety 33 (5) (2024)
Jodi B Segal, Ravi Varadhan, Rolf H H Groenwold, Xiaojuan Li, Kaori Nomura, Sigal Kaplan, Shirin Ardeshir-Rouhani-Fard, James Heyward, Fredrik Nyberg, Mehmet Burcu
Assessing Heterogeneity of Treatment Effect in Real-World Data. Annals of internal medicine (2023)
Gerold T Wharton, Claudia Becker, Dimitri Bennett, Mehmet Burcu, Greta Bushnell, Carmen Ferrajolo, Sigal Kaplan, Ann W McMahon, Naimisha Movva, Sudha R Raman, Oliver Scholle, Mina Suh, Jenny W Sun, Daniel B Horton
Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiology and drug safety (2023)
Jodi B Segal, Ravi Varadhan, Rolf H H Groenwold, Xiaojuan Li, Kaori Nomura, Sigal Kaplan, Shirin Ardeshir-Rouhani-Fard, James Heyward, Fredrik Nyberg, Mehmet Burcu
Assessing Heterogeneity of Treatment Effect in Real-World Data. Annals of internal medicine (2023)
Sigal Kaplan, Mikhail Zeygarnik, Tal Stern, Kerstin Hellwig
Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy. European journal of neurology (2023)
Catherine B Johannes, Catherine W Saltus, James A Kaye, Brian Calingaert, Sigal Kaplan, Mark Forrest Gordon, Elizabeth B Andrews
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database. Pharmacoepidemiology and drug safety 31 (6) (2022)
Sigal Kaplan, Monica L Bertoia, Amir Lass, Florence T Wang, Alison Evans, Sandeep Dhanda, Debabrata Roy, John D Seeger
Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study. Pharmacoepidemiology and drug safety (2022)
Birgit Ehlken, Chihiro Nishikawa, Sigal Kaplan, Isabelle Dresco, Denis Granados, Massoud Toussi
Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK. Current medical research and opinion 38 (3) (2022)
Sigal Kaplan, Mikhail Zeygarnik, Tal Stern
Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding. Drug safety 45 (4) (2022)
Sigal Kaplan, Dana Ilic Bogojevic, Carolyn Rainville, Nicholas Gross
A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (11) (2022)
Sigal Kaplan, Massoud Toussi, Alison Evans, Sandeep Dhanda, Debabrata Roy, Amir Lass
Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database study. Current medical research and opinion 37 (3) (2021)
Sigal Kaplan, Aurore Bergamasco, Martin Sergerie, Anne-Marie Castilloux, Yola Moride
Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance. Drug safety 43 (2) (2020)
Nencho Nenchev, Jiri Skopek, Deepa Arora, Abdus Samad, Sigal Kaplan, Mónika Domahidy, Hanka de Voogd, Stella Böhmert, Rita S Ramos, Shashank Jain
Effect of age and renal impairment on the pharmacokinetics and safety of trimetazidine: An open-label multiple-dose study. Drug development research 81 (5) (2020)
Massoud Toussi, Margarita Shlaen, Florence Coste, Hanka de Voogd, Vasilis Dimos, Sigal Kaplan
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe. Pharmacoepidemiology and drug safety 30 (3) (2020)
Massoud Toussi, Bardoulat Isabelle, Stephanie Tcherny-Lessenot, Hanka de Voogd, Vasilis Dimos, Sigal Kaplan
Effectiveness of risk minimisation measures for valproate: A cross-sectional survey among physicians in Europe. Pharmacoepidemiology and drug safety 30 (3) (2020)
Sigal Kaplan, Oliver Patino, Carolyn Rainville, Terri Madison
Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study. Pharmacoepidemiology and drug safety 29 (2) (2019)
Sigal Kaplan, Birgit Ehlken, Xenia Hamann
Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany. Current medical research and opinion 35 (8) (2019)
Sigal Kaplan, Nicole Lang, Maja Gasparic, Carolyn Rainville, George Haralabopoulos, Emanuele Borroni
Prescribing patterns from medical chart abstraction of patients administered lipegfilgrastim: a pilot study in Europe. Journal of drug assessment 8 (1) (2019)
Sigal Kaplan, Earl L Goehring, Sigal Melamed-Gal, Bao-Anh Nguyen-Khoa, Helena Knebel, Judith K Jones
Modafinil and the risk of cardiovascular events: Findings from three US claims databases. Pharmacoepidemiology and drug safety 27 (11) (2018)
Dorothea von Bredow, Massoud Toussi, Abdus Samad, Sigal Kaplan, Mónika Domahidy, Hanka de Voogd, Stella Böhmert, Rita Silveira Ramos, Deepa Arora
Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries. Pharmacoepidemiology and drug safety 27 (12) (2018)
Sigal Kaplan, Birgit Ehlken, Xenia Hamann
The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany. Current medical research and opinion 35 (1) (2018)